Company profile

History

The Company began business in 1989. In the second year of activity a commercial division was created and work also started on a plant for pharmaceutical production in Prague. The Company has been operating under the name PRO.MED.CS Praha a.s. since 1993.
During its existence this small Company has grown to become a medium-sized business with a strong and respected position on the Czech market and in other countries in Central and Eastern Europe and Central Asia. The Company currently employs around 400 people.

Range

The Company supplies the market with most of the drugs it produces. The Company devotes the same level of care to imported and distributed pharmaceuticals as to its own range. PRO.MED.CS Praha a.s. currently represents in the Czech Republic and abroad a dozen well-known companies predominantly from Western Europe, such as Germany, Spain and France.

Quality care

Special attention is paid to ensuring quality. Production and monitoring processes at PRO.MED.CS Praha a.s. meet all the requirements expected of pharmaceutical production in the EU. State regulatory authorities periodically verify that the rules concerning production, monitoring and distribution of drugs are being adhered to. The aim of these audits is to ensure the quality, efficiency and safety of drugs from the stage of research & development via production, control, and the complete distribution chain right up to the final user – the patient.
The high quality of produced pharmaceuticals is guaranteed by the regular quality control of the outgoing substances at modern laboratories where the procedures under the European Pharmacopoeia are enforced.

Research and development

A pharmaceutical Company’s long-term success depends to a large extent on the research and development of new preparations and on successful innovation. PRO.MED.CS Praha a.s. has its own formulation development for fixed dosafe forms from lab scale to pilot scale.

Position on the market

PRO.MED.CS Praha a.s. is a well-established pharmaceutical Company which, thanks to its carefully selected portfolio and correct marketing policy, has built up a strong position on the Czech market and is penetrating more and more new foreign markets. Currently 73% of the Company’s turnover is exported. The share of export of the Company’s total sales has continued to rise in recent years and this trend can be expected to continue in future years.

Partnerships

Due to its wide experience and good results in trading with the markets of Central and Eastern Europe PRO.MED.CS Praha a.s. has become an attractive partner to work with. The Company has signed several strategic contracts with pharmaceutical firms abroad with the aim of expanding its portfolio.

Marketing and logistics

A significant part of the service PRO.MED.CS Praha a.s. offers to its partners is in the marketing and logistics of their products. The cooperation with its partners, which are mostly large companies from the EU, is usually based on exclusive representation. PRO.MED.CS Praha a.s. provides a whole spectrum of services for most of these companies – ranging from market research, registration of preparations, marketing to logistics and sales.